Singaporean medical services provider Fullerton Healthcare Corp. has chosen Bank of America Corp. to advise it on a sale as the coronavirus pandemic drives increasing interest in health care companies, according to people with knowledge of the matter.

The potential sale would not include Fullerton Health’s operations in Australia, said the people, who asked not to be identified as the information is private. The owners of the medical chain, including Singaporean private equity firm SIN Capital Group, are reviving the previously stalled sale because the pandemic has helped boost Fullerton Health’s business, said one of the people.

The company’s annualized earnings before interest, taxes, depreciation and amortization for 2020 were about $149 million, another person said. The sale process could begin as soon as this quarter, the person said.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Related Stories

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook